Kengo Takeuchi
Kengo Takeuchi
Cancer Institute, Japanese Foundation for Cancer Research
Verified email at - Homepage
Cited by
Cited by
RET, ROS1 and ALK fusions in lung cancer
K Takeuchi, M Soda, Y Togashi, R Suzuki, S Sakata, S Hatano, R Asaka, ...
Nature Medicine 18 (3), 378-381, 2012
EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors
YL Choi, M Soda, Y Yamashita, T Ueno, J Takashima, T Nakajima, ...
New England Journal of Medicine 363 (18), 1734-1739, 2010
KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer
K Takeuchi, YL Choi, Y Togashi, M Soda, S Hatano, K Inamura, S Takada, ...
Clinical cancer research 15 (9), 3143-3149, 2009
Integrated molecular analysis of adult T cell leukemia/lymphoma
K Kataoka, Y Nagata, A Kitanaka, Y Shiraishi, T Shimamura, J Yasunaga, ...
Nature genetics 47 (11), 1304-1315, 2015
Somatic RHOA mutation in angioimmunoblastic T cell lymphoma
M Sakata-Yanagimoto, T Enami, K Yoshida, Y Shiraishi, R Ishii, Y Miyake, ...
Nature genetics 46 (2), 171-175, 2014
A mouse model for EML4-ALK-positive lung cancer
M Soda, S Takada, K Takeuchi, YL Choi, M Enomoto, T Ueno, H Haruta, ...
Proceedings of the National Academy of Sciences 105 (50), 19893, 2008
CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study
T Seto, K Kiura, M Nishio, K Nakagawa, M Maemondo, A Inoue, T Hida, ...
The lancet oncology 14 (7), 590-598, 2013
Frequent inactivation of A20 in B-cell lymphomas
M Kato, M Sanada, I Kato, Y Sato, J Takita, K Takeuchi, A Niwa, Y Chen, ...
Nature 459 (7247), 712-716, 2009
Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
K Kataoka, Y Shiraishi, Y Takeda, S Sakata, M Matsumoto, S Nagano, ...
Nature 534 (7607), 402-406, 2016
Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts
K Takeuchi, YL Choi, M Soda, K Inamura, Y Togashi, S Hatano, ...
Clinical cancer research 14 (20), 6618-6624, 2008
EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers
K Inamura, K Takeuchi, Y Togashi, K Nomura, H Ninomiya, M Okui, ...
Journal of Thoracic Oncology 3 (1), 13, 2008
Identification of novel isoforms of the EML4-ALK transforming gene in non–small cell lung cancer
YL Choi, K Takeuchi, M Soda, K Inamura, Y Togashi, S Hatano, ...
Cancer research 68 (13), 4971-4976, 2008
EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset
K Inamura, K Takeuchi, Y Togashi, S Hatano, H Ninomiya, N Motoi, ...
Modern pathology 22 (4), 508-515, 2009
Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients
T Oyama, K Yamamoto, N Asano, A Oshiro, R Suzuki, Y Kagami, ...
Clinical cancer research 13 (17), 5124-5132, 2007
Two novel ALK mutations mediate acquired resistance to the next-generation ALK inhibitor alectinib
R Katayama, L Friboulet, S Koike, EL Lockerman, TM Khan, JF Gainor, ...
Clinical cancer research 20 (22), 5686-5696, 2014
KLC1-ALK: A Novel Fusion in Lung Cancer Identified Using a Formalin-Fixed Paraffin-Embedded Tissue Only
Y Togashi, M Soda, S Sakata, E Sugawara, S Hatano, R Asaka, ...
PloS one 7 (2), e31323, 2012
Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations
N Tomita, M Tokunaka, N Nakamura, K Takeuchi, J Koike, S Motomura, ...
Haematologica 94 (7), 935-943, 2009
Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype
R Suzuki, Y Kagami, K Takeuchi, M Kami, M Okamoto, R Ichinohasama, ...
Blood 96 (9), 2993-3000, 2000
Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non–small cell lung cancer
B Gong, K Kiyotani, S Sakata, S Nagano, S Kumehara, S Baba, B Besse, ...
Journal of Experimental Medicine 216 (4), 982-1000, 2019
TRANSPLANTATION-Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease
Y Sakoda, D Hashimoto, S Asakura, K Takeuchi, M Harada, M Tanimoto, ...
Blood 109 (4), 1756, 2010
The system can't perform the operation now. Try again later.
Articles 1–20